X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-26 | PYXS | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.96 | +88,850 | 2,314,886 | +4% | +$174,364 | ||||||
2023-09-28 | PYXS | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.87 | +8,000 | 818,532 | +1% | +$14,960 | ||||||
2023-09-27 | PYXS | Wadhane Jitendra | Chief Accounting Officer | P - Purchase | $1.87 | +2,500 | 226,937 | +1% | +$4,675 | ||||||
2023-09-27 | PYXS | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.85 | +6,426 | 810,532 | +1% | +$11,868 | ||||||
2023-09-25 | PYXS | Wadhane Jitendra | Chief Accounting Officer | P - Purchase | $1.77 | +5,000 | 224,437 | +2% | +$8,850 | ||||||
2023-09-25 | PYXS | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.67 | +12,000 | 804,106 | +2% | +$20,044 | ||||||
2023-09-22 | PYXS | Wadhane Jitendra | Chief Accounting Officer | P - Purchase | $1.74 | +2,500 | 219,437 | +1% | +$4,349 | ||||||
2023-09-22 | PYXS | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.74 | +5,000 | 792,106 | +1% | +$8,695 | ||||||
| M | 2023-09-14 | PYXS | Sullivan Lara | Pres, CEO | S - Sale | $2.10 | -8,641 | 2,403,882 | 0% | -$18,161 | |||||
| M | 2023-09-11 | PYXS | Sullivan Lara | Pres, CEO | S - Sale | $2.27 | -27,917 | 2,412,523 | -1% | -$63,301 | |||||
| A | 2023-03-17 | PYXS | Pfizer Inc | 10% | P - Purchase | $2.76 | +1,811,594 | 5,952,263 | +44% | +$4,999,999 | |||||
2023-03-17 | PYXS | Pfizer Inc | 10% | P - Purchase | $2.76 | +1,811,594 | 7,032,770 | +35% | +$4,999,999 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |